Kyntra Bio (KYNB)

• Market cap: $30.8M
• 1 day: 3.96%
• 5 days: 2.7%
• 1 month: 13.75%
• 3 months: 6.14%
• 6 months: -16.1%
• Year to date: -16.92%
• 1 year: 3.54%
• 5 years: -98.8%
• 10 years: -98.23%
• Sector: Healthcare
• Industry: Biotechnology

About: Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.

Employees: 34